Login to Your Account

Prosensa Holding Hops Over the Pond for Nasdaq Debut

By Catherine Shaffer
Staff Writer

Monday, July 1, 2013

Prosensa Holding B.V., of Leiden, the Netherlands, became the first European biotech company in 10 years to file for its initial public offering (IPO) on the Nasdaq to support development of its products for Duchenne's muscular dystrophy and other programs. It plans to raise about $78 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription